Noema raises $60 million series A to develop 4 neurological drugs licensed from Roche

Retrieved on: 2020-12-05 11:32:31

Tags for this article:

Organ systems

Nervous system

Neurological disorders

Click the tags to see associated articles and topics

Noema raises $60 million series A to develop 4 neurological drugs licensed from Roche. View article details on hiswai:

Excerpt

<b>Roche</b> previously tested the drug for fragile X syndrome and depression with disappointing results. Noema will also test a PDE10A inhibitor in a Phase ...

Article found on: cen.acs.org

View Original Article